The BÜHLMANN Calprotectin ELISA has been successfully introduced to the Charles University in Prague.
In a clinical evaluation study the monoclonal assay by BÜHLMANN was used to analyze fecal samples from patients with Crohn's, ulcerous colitis and from healthy controls, resulting in excellent sensitivities and specificities. The results by the BÜHLMANN Calprotectin ELISA were also superior to the determination of this protein by using polyclonal antibodies in other tests.